# Patent

## Title
Plant tubby-like proteins

## Abstract

An isolated polypeptide containing an amino acid sequence at least 70% identical to a Tubby-like protein (SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11), and an isolated nucleic acid encoding the polypeptide. Disclosed is an isolated nucleic acid that, under stringent conditions, hybridizes to a probe containing one of SEQ ID NOs:1-11; or its complementary sequence. Also disclosed are (1) a transformed cell or a transgenic plant containing such a nucleic acid and (2) a transformed cell or a transgenic plant having a reduced level(s) of one or more of the Tubby-like proteins. Also within the scope of the invention are methods for making the transformed cells or transgenic plants.

## Background
RELATED APPLICATION
This application is a continuation-in-part application of U.S. patent application Ser. No. 11/940,369, filed Nov. 15, 2007 and now abandoned, which is a divisional application of U.S. patent application Ser. No. 10/763,042, filed Jan. 21, 2004, now U.S. Pat. No. 7,314,756, which claims priority from U.S. Provisional Application No. 60/441,380, filed Jan. 21, 2003. The contents of all of the prior applications are incorporated by reference in their entirety.


BACKGROUND
Various environmental factors, e.g., high salinity, pathogens, and chilling, cause stress and adverse effects on growth and productivity of crops. It is therefore desirable to produce transgenic crops that are tolerant to such factors. Genetic engineering can be used to modify proteins that are involved in regulating responses of plants to environmental factors, thereby improving stress-tolerance.
TUBBY proteins, a group of membrane-bound transcription regulators, were first identified from obese mice via positional cloning (Kleyn et al., 1996, Cell 85: 281-290 and Noben-Trauth et al., 1996, Nature 380: 534-538.). Mutations in the TUBBY genes lead to maturity-onset obesity, insulin resistance, retinal degeneration, and neurosensory hearing loss. TUBBY-like proteins (TLPs) were subsequently discovered in other mammals and were found to be activated through G-proteins, which, in higher plants, are involved in the response to environmental factors and hormone regulation (Warpeha et al., 1991, Proc. Natl. Acad. Sci. 88: 8925-8929, and Ueguchi-Tanaka et al., Proc. Natl. Acad. Sci. 97: 11638-11643).
SUMMARY
This invention is based on the discovery of eleven Arabidopsis TUBBY-like proteins, designated as AtTLPs 1-11. These proteins regulate the response of Arabidopsis to environmental factors. The full-length AtTLPs 1-11 polypeptides (designated as SEQ ID NOs: 1-11), and cDNAs encoding the polypeptides (designated as SEQ ID NOs: 12-22), are shown below:








AtTLP1:



polypeptide:


(SEQ ID NO: 1)



   1 MSFRSIVRDV RDSIGSLSRR SFDFKLSSLN KEGGKSRGSV QDSHEEQLVV



 


  51 TIQETPWANL PPELLRDVIK RLEESESVWP ARRHVVACAS VCRSWRDMCK


 


 101 EIVQSPELSG KITFPVSLKQ PGPRDATMQC FIKRDKSNLT YHLYLCLSPA


 


 151 LLVENGKFLL SAKRIRRTTY TEYVISMHAD TISRSSNTYI GKIRSNFLGT


 


 201 KFIIYDTQPA YNSNIARAVQ PVGLSRRFYS KRVSPKVPSG SYKIAQVSYE


 


 251 LNVLGTRGPR RMHCAMNSIP ASSLAEGGTV PGQPDIIVPR SILDESFRSI


 


 301 TSSSSRKITY DYSNDFSSAR FSDILGPLSE DQEVVLEEGK ERNSPPLVLK


 


 351 NKPPRWHEQL QCWCLNFRGR VTVASVKNFQ LIAANQPQPQ PQPQPQPQPL


 


 401 TQPQPSGQTD GPDKIILQFG KVGKDMFTMD FRYPLSAFQA FAICLSSFDT


 


 451 KLACE


 









cDNA:




(SEQ ID NO: 12)




   1 ATGTCGTTCC GTAGCATAGT TCGTGATGTG AGAGATAGTA TAGGAAGTCT




 


  51 ATCGAGGCGT AGTTTCGACT TTAAGTTAAG CAGCTTGAAC AAAGAAGGTG



 


 101 GTAAATCCCG TGGTTCGGTT CAAGATTCTC ATGAGGAACA ACTTGTAGTA



 


 151 ACGATTCAAG AAACACCGTG GGCGAATCTA CCTCCAGAGT TATTACGTGA



 


 201 TGTGATCAAA AGACTTGAAG AGAGTGAAAG TGTGTGGCCT GCTCGTAGAC



 


 251 ATGTTGTTGC TTGTGCTTCT GTTTGCAGGT CATGGAGAGA TATGTGTAAA



 


 301 GAGATTGTTC AAAGTCCGGA GCTCTCAGGC AAAATCACAT TTCCTGTTTC



 


 351 GTTGAAACAG CCTGGACCAA GAGATGCAAC AATGCAATGC TTTATCAAAA



 


 401 GGGATAAATC TAACTTGACT TATCATTTAT ATCTTTGTCT CAGTCCTGCT



 


 451 TTGTTGGTTG AGAATGGAAA GTTTCTTCTT TCTGCAAAAC GCATAAGAAG



 


 501 AACTACATAC ACCGAGTACG TGATCTCTAT GCACGCCGAC ACCATTTCGA



 


 551 GATCAAGCAA TACCTACATT GGCAAAATCA GGTCTAATTT TCTGGGGACG



 


 601 AAGTTTATAA TATACGATAC ACAACCAGCA TACAACAGCA ACATCGCTCG



 


 651 AGCGGTCCAA CCGGTAGGTC TTAGCCGCAG ATTCTACTCA AAGAGAGTCT



 


 701 CTCCCAAAGT ACCTAGTGGG AGCTACAAAA TTGCGCAGGT TTCTTATGAG



 


 751 CTAAACGTTC TTGGTACCCG TGGTCCGAGG AGAATGCATT GTGCGATGAA



 


 801 CTCAATTCCC GCCTCTTCCC TTGCGGAAGG CGGAACTGTG CCTGGACAGC



 


 851 CCGATATCAT TGTCCCGCGC TCTATTCTCG ACGAATCGTT CCGCAGCATT



 


 901 ACCTCTTCGT CATCGAGAAA AATCACTTAC GATTACTCGA ATGATTTTAG



 


 951 CAGTGCACGG TTTTCCGACA TTCTTGGCCC GTTAAGCGAA GACCAAGAAG



 


1001 TGGTATTAGA AGAAGGGAAA GAGCGGAATT CGCCACCACT TGTGCTTAAG



 


1051 AACAAGCCGC CGAGGTGGCA TGAACAGCTT CAGTGTTGGT GTTTAAACTT



 


1101 CAGGGGACGT GTAACAGTCG CATCAGTTAA GAACTTTCAG CTCATTGCAG



 


1151 CAAACCAACC ACAGCCTCAG CCTCAGCCTC AACCGCAACC TCAACCCCTA



 


1201 ACTCAGCCGC AACCGTCTGG TCAGACCGAT GGTCCCGACA AGATCATATT



 


1251 GCAGTTTGGG AAAGTGGGAA AAGACATGTT CACGATGGAT TTCCGGTATC



 


1301 CGCTCTCTGC GTTTCAGGCT TTCGCTATCT GTTTGAGCAG TTTCGACACA



 


1351 AAACTTGCTT GCGAA



 


AtTLP2:



polypeptide:



(SEQ ID NO: 2)




   1 MSLKSILRDL KEVRDGLGGI SKRSWSKSSH IAPDQTTPPL DNIPQSPWAS




 


  51 LPPELLHDII WRVEESETAW PARAAVVSCA SVCKSWRGIT MEIVRIPEQC



 


 101 GKLTFPISLK QPGPRDSPIQ CFIKRNRATA TYILYYGLMP SETENDKLLL



 


 151 AARRIRRATC TDFIISLSAK NFSRSSSTYV GKLRSGFLGT KFTIYDNQTA



 


 201 SSTAQAQPNR RLHPKQAAPK LPTNSSTVGN ITYELNVLRT RGPRRMHCAM



 


 251 DSIPLSSVIA EPSVVQGIEE EVSSSPSPKG ETITTDKEIP DNSPSLRDQP



 


 301 LVLKNKSPRW HEQLQCWCLN FKGRVTVASV KNFQLVAEID ASLDAPPEEH



 


 351 ERVILQFGKI GKDIFTMDYR YPLSAFQAFA ICISSFDTKP ACEG



 


cDNA:



(SEQ ID NO: 13)




   1 ATGTCTTTGA AAAGCATCCT TCGTGATCTG AAGGAAGTGA GGGATGGACT




 


  51 TGGAGGCATC TCCAAGAGAA GCTGGTCAAA GTCGTCTCAC ATTGCTCCTG



 


 101 ATCAAACAAC TCCACCACTG GATAACATAC CACAGAGCCC ATGGGCTTCT



 


 151 TTGCCGCCTG AGTTGCTTCA TGACATTATC TGGAGGGTTG AAGAGAGTGA



 


 201 GACAGCTTGG CCCGCTCGAG CTGCCGTTGT CTCTTGTGCT TCAGTATGTA



 


 251 AATCATGGAG AGGAATCACT ATGGAGATTG TGAGGATCCC TGAGCAGTGT



 


 301 GGGAAGCTCA CTTTTCCAAT CTCATTGAAA CAGCCGGGGC CTCGAGACTC



 


 351 TCCAATTCAA TGTTTTATTA AGAGGAACAG AGCAACAGCT ACATACATTC



 


 401 TCTATTATGG TTTGATGCCT TCGGAGACTG AGAACGACAA ACTGTTGTTA



 


 451 GCAGCAAGAA GGATTAGAAG AGCGACATGC ACAGACTTTA TAATCTCCCT



 


 501 ATCTGCAAAG AACTTCTCAC GGAGCAGCAG TACTTATGTT GGCAAATTAA



 


 551 GGTCTGGTTT TCTGGGAACC AAGTTCACAA TATATGACAA CCAAACAGCA



 


 601 TCATCCACAG CACAAGCCCA ACCTAACCGA AGACTCCACC CGAAACAAGC



 


 651 GGCTCCTAAA CTACCTACGA ATAGCTCTAC CGTAGGAAAC ATAACCTACG



 


 701 AGCTCAATGT TCTTCGCACA AGGGGACCTA GAAGAATGCA CTGCGCTATG



 


 751 GATTCTATAC CCCTCTCTTC TGTTATTGCT GAACCGTCAG TAGTTCAAGG



 


 801 CATAGAAGAG GAAGTCTCTT CCTCTCCTTC ACCAAAAGGA GAAACCATCA



 


 851 CAACAGACAA AGAGATTCCT GATAATTCTC CAAGCTTAAG GGACCAACCG



 


 901 CTAGTTCTCA AAAACAAATC CCCAAGATGG CATGAGCAGT TGCAGTGCTG



 


 951 GTGCCTCAAC TTCAAGGGAA GAGTGACTGT GGCTTCAGTT AAGAATTTCC



 


1001 AGCTTGTTGC AGAGATTGAC GCTTCTTTGG ATGCGCCGCC TGAAGAACAT



 


1051 GAGAGGGTGA TCTTACAGTT TGGCAAAATC GGTAAGGATA TTTTCACCAT



 


1101 GGATTATCGC TACCCTCTAT CTGCTTTTCA AGCCTTTGCT ATATGCATTA



 


1151 GCAGCTTTGA CACCAAACCG GCATGTGAAG GG 



 


AtTLP3:



polypeptide:



(SEQ ID NO: 3)




   1 MSFKSLIQDM RGELGSISRK GFDVRFGYGR SRSQRVVQDT SVPVDAFKQS




 


  51 CWASMPPELL RDVLMRIEQS EDTWPSRKNV VSCAGVCRNW REIVKEIVRV



 


 101 PELSSKLTFP ISLKQPGPRG SLVQCYIMRN RSNQTYYLYL GLNQAASNDD



 


 151 GKFLLAAKRF RRPTCTDYII SLNCDDVSRG SNTYIGKLRS NFLGTKFTVY



 


 201 DAQPTNPGTQ VTRTRSSRLL SLKQVSPRIP SGNYPVAHIS YELNVLGSRG



 


 251 PRRMQCVMDA IPASAVEPGG TAPTQTELVH SNLDSFPSFS FFRSKSIRAE



 


 301 SLPSGPSSAA QKEGLLVLKN KAPRWHEQLQ CWCLNFNGRV TVASVKNFQL



 


 351 VAAPENGPAG PEHENVILQF GKVGKDVFTM DYQYPISAFQ AFTICLSSFD



 


 401 TKIACE



 


cDNA:



(SEQ ID NO: 14)










   1 ATGTCCTTCA AGAGTCTCAT TCAGGACATG AGAGGAGAGC TTGGGAGTAT



 


  51 ATCCAGAAAG GGATTCGATG TCAGATTCGG GTATGGTAGA TCCAGGTCTC


 


 101 AACGTGTTGT TCAGGATACT TCTGTTCCTG TTGATGCTTT CAAGCAGAGC


 


 151 TGCTGGGCTA GTATGCCTCC GGAGCTCCTG AGAGATGTTC TTATGAGGAT


 


 201 TGAGCAATCC GAAGACACTT GGCCGTCTAG GAAAAATGTT GTTTCTTGCG


 


 251 CTGGTGTCTG CAGGAACTGG CGAGAAATCG TCAAAGAGAT CGTCAGAGTT


 


 301 CCTGAGCTTT CTAGCAAACT CACTTTTCCT ATCTCCCTCA AACAGCCGGG


 


 351 TCCTAGAGGA TCACTTGTTC AATGCTATAT TATGAGAAAC CGCAGCAATC


 


 401 AAACCTACTA TCTATACCTC GGGTTAAACC AAGCAGCTTC AAATGATGAT


 


 451 GGAAAGTTCC TTCTTGCTGC CAAGAGGTTT CGGAGGCCAA CTTGCACTGA


 


 501 CTACATCATC TCCTTAAACT GCGATGATGT CTCTCGAGGA AGCAATACCT


 


 551 ATATCGGAAA GCTTAGATCT AACTTTCTGG GGACCAAGTT CACTGTCTAT


 


 601 GACGCTCAGC CGACGAATCC TGGAACTCAG GTTACCAGAA CCCGTTCAAG


 


 651 CAGACTTCTC AGTTTGAAAC AAGTGAGCCC GAGAATTCCA TCTGGCAACT


 


 701 ATCCTGTAGC ACATATCTCA TATGAGCTTA ACGTCTTGGG TTCCAGAGGA


 


 751 CCGAGGAGGA TGCAGTGTGT CATGGATGCC ATCCCTGCAT CAGCTGTAGA


 


 801 ACCTGGAGGA ACAGCTCCAA CTCAGACGGA ACTTGTCCAT AGCAATCTTG


 


 851 ATAGTTTCCC CTCATTCTCC TTCTTCAGGT CGAAATCAAT TCGTGCAGAG


 


 901 AGTCTCCCTT CTGGTCCATC ATCTGCTGCT CAGAAGGAAG GACTGCTTGT


 









 951 CCTGAAAAAC AAAGCGCCCA GATGGCACGA ACAGCTCCAG TGCTGGTGCC




 


1001 TCAACTTCAA TGGGAGAGTC ACAGTTGCTT CCGTCAAAAA CTTTCAGCTG



 


1051 GTAGCTGCTC CTGAGAATGG ACCTGCAGGA CCTGAGCACG AAAACGTGAT



 


1101 TCTCCAGTTT GGAAAAGTCG GAAAAGATGT GTTCACAATG GATTATCAGT



 


1151 ACCCTATCTC TGCCTTCCAG GCCTTCACCA TTTGCCTCAG CAGTTTCGAC



 


1201 ACCAAGATAG CATGTGAA



 


AtTLP4:



polypeptide:



(SEQ ID NO: 4)




   1 MPPELLRDVL MRIERSEDTW PSRKNVVSCV GVCKNWRQIF KEIVNVPEVS




 


  51 SKFTFPISLK QPGPGGSLVQ CYVKRNRSNQ TFYLYLGGEA KIFCQSEPSD



 


 101 IYLVPYSYRE THCVMDAISA SAVKPGGTAT TQTELDNFVS FRSPSGQKEG



 


 151 VLVLKSKVPR LEEQSWCLDF NGSPENEPEN ENDIFQFAKV GNLHKLFSLY



 


 201 EAEWIPLVRT SVFAVIARVC RDKKHTPSYE LKLALYFAKN SAILKKFVLR



 


 251 GYTREEDLLA LPVAN



 


cDNA:



(SEQ ID NO: 15)




   1 ATGCCTCCTG AGCTTCTGAG AGATGTTCTG ATGAGGATAG AGCGATCCGA




 


  51 AGACACTTGG CCTTCTAGGA AGAATGTTGT TTCTTGTGTA GGTGTGTGTA



 


 101 AGAACTGGCG ACAAATATTC AAAGAGATCG TTAACGTTCC TGAGGTTTCT



 


 151 AGCAAATTCA CTTTTCCAAT CTCCTTGAAA CAGCCTGGTC CAGGAGGATC



 


 201 ACTTGTTCAA TGCTATGTTA AGAGAAACCG TAGCAATCAA ACTTTCTATC



 


 251 TATACCTTGG AGGTGAAGCA AAAATATTTT GTCAGTCTGA ACCAAGTGAT



 


 301 ATTTATCTCG TTCCTTACAG TTACAGAGAG ACGCATTGCG TCATGGATGC



 


 351 CATCTCTGCA TCAGCAGTAA AACCTGGAGG AACAGCTACA ACTCAGACAG



 


 401 AACTCGATAA TTTCGTGTCA TTCAGGTCTC CTTCTGGTCA AAAGGAAGGA



 


 451 GTGCTTGTTC TTAAGAGCAA AGTGCCTAGA TTGGAAGAAC AGAGCTGGTG



 


 501 TCTCGACTTC AATGGCTCTC CTGAGAACGA ACCTGAGAAT GAAAACGACA



 


 551 TTTTCCAGTT TGCGAAAGTC GGAAACTTGC ACAAACTCTT CAGTTTATAT



 


 601 GAGGCTGAAT GGATTCCTCT CGTTCGCACC TCAGTGTTTG CTGTCATTGC



 


 651 TCGAGTTTGT AGAGATAAAA AGCATACACC ATCGTATGAA TTGAAACTTG



 


 701 CATTGTACTT TGCAAAAAAC TCTGCAATCC TCAAGAAATT CGTTCTCCGC



 


 751 GGTTACACTC GAGAAGAAGA TTTACTCGCA TTGCCCGTGG CTAAC



 


AtTLP5:



polypeptide:



(SEQ ID NO: 5)




   1 MSFLSIVRDV RDTVGSFSRR SFDVRVSNGT THQRSKSHGV EAHIEDLIVI




 


  51 KNTRWANLPA ALLRDVMKKL DESESTWPAR KQVVACAGVC KTWRLMCKDI



 


 101 VKSPEFSGKL TFPVSLKQPG PRDGIIQCYI KRDKSNMTYH LYLSLSPAIL



 


 151 VESGKFLLSA KRSRRATYTE YVISMDADNI SRSSSTYIGK LKSNFLGTKF



 


 201 IVYDTAPAYN SSQILSPPNR SRSFNSKKVS PKVPSGSYNI AQVTYELNLL



 


 251 GTRGPRRMNC IMHSIPSLAL EPGGTVPSQP EFLQRSLDES FRSIGSSKIV



 


 301 NHSGDFTRPK EEEGKVRPLV LKTKPPRWLQ PLRCWCLNFK GRVTVASVKN



 


 351 FQLMSAATVQ PGSGSDGGAL ATRPSLSPQQ PEQSNHDKII LHFGKVGKDM



 


 401 FTMDYRYPLS AFQAFAISLS TFDTKLACE



 


cDNA:



(SEQ ID NO: 16)




   1 ATGTCGTTTC TGAGTATTGT TCGTGATGTT AGAGATACTG TAGGAAGCTT




 


  51 TTCGAGACGT AGTTTCGACG TGAGAGTATC TAATGGGACG ACTCATCAGA



 


 101 GGAGTAAATC TCACGGTGTT GAGGCACATA TTGAAGATCT TATTGTAATC



 


 151 AAGAACACTC GTTGGGCTAA TTTACCGGCT GCGCTATTAC GAGATGTGAT



 


 201 GAAAAAGTTG GATGAAAGCG AGAGTACTTG GCCTGCACGT AAACAAGTCG



 


 251 TTGCTTGTGC TGGTGTCTGC AAGACATGGA GACTAATGTG CAAAGATATT



 


 301 GTGAAAAGTC CTGAGTTCTC AGGCAAACTC ACATTTCCAG TTTCGTTGAA



 


 351 ACAGCCCGGG CCTAGGGATG GAATCATACA ATGTTATATC AAAAGAGACA



 


 401 AGTCTAACAT GACTTACCAC CTTTACCTTT CTCTTAGTCC TGCCATACTT



 


 451 GTTGAAAGTG GGAAGTTTCT TCTCTCGGCA AAGCGCTCAC GGAGAGCTAC



 


 501 ATACACAGAG TATGTAATAT CAATGGATGC AGACAACATT TCAAGATCAA



 


 551 GCAGCACTTA CATTGGCAAA CTGAAGTCTA ACTTTCTAGG GACAAAATTT



 


 601 ATAGTATATG ATACGGCTCC TGCGTACAAC AGTAGCCAGA TATTGTCCCC



 


 651 ACCAAACCGG AGTCGTAGTT TCAACTCCAA GAAAGTGTCT CCCAAAGTCC



 


 701 CTTCTGGAAG TTACAACATT GCTCAAGTTA CATACGAGCT GAACTTGCTT



 


 751 GGAACCCGTG GACCTCGTAG AATGAACTGC ATTATGCACT CTATCCCCTC



 


 801 CTTAGCTCTA GAACCCGGAG GTACTGTCCC TAGCCAACCT GAGTTTCTAC



 


 851 AACGTTCCCT TGATGAATCT TTCCGCAGCA TCGGTTCCTC AAAGATAGTC



 


 901 AACCACTCGG GAGATTTCAC CCGACCGAAA GAGGAAGAAG GAAAGGTGCG



 


 951 ACCTTTGGTA CTGAAAACTA AACCGCCAAG GTGGCTCCAA CCGTTGCGAT



 


1001 GTTGGTGCCT TAACTTCAAA GGGAGAGTGA CTGTAGCTTC TGTCAAGAAC



 


1051 TTCCAGTTGA TGTCCGCTGC AACGGTTCAG CCCGGTAGTG GTAGTGATGG



 


1101 TGGAGCATTG GCTACGAGGC CATCGTTATC ACCACAGCAG CCAGAGCAAT



 


1151 CAAACCATGA TAAGATAATA CTACACTTTG GGAAAGTGGG TAAGGATATG



 


1201 TTCACTATGG ACTATCGTTA TCCTCTCTCT GCCTTTCAAG CGTTTGCCAT



 


1251 TTCCCTGAGC ACCTTTGATA CTAAATTGGC ATGTGAA



 


AtTLP6:



polypeptide:



(SEQ ID NO: 6)




   1 MSLKNIVKNK YKAIGRRGRS HIAPEGSSVS SSLSTNEGLN QSIWVDLPPE




 


  51 LLLDIIQRIE SEQSLWPGRR DVVACASVCK SWREMTKEVV KVPELSGLIT



 


 101 FPISLRQPGP RDAPIQCFIK RERATGIYRL YLGLSPALSG DKSKLLLSAK



 


 151 RVRRATGAEF VVSLSGNDFS RSSSNYIGKL RSNFLGTKFT VYENQPPPFN



 


 201 RKLPPSMQVS PWVSSSSSSY NIASILYELN VLRTRGPRRM QCIMHSIPIS



 


 251 AIQEGGKIQS PTEFTNQGKK KKKPLMDFCS GNLGGESVIK EPLILKNKSP



 


 301 RWHEQLQCWC LNFKGRVTVA SVKNFQLVAA AAEAGKNMNI PEEEQDRVIL



 


 351 QFGKIGKDIF TMDYRYPISA FQAFAICLSS FDTKPVCE



 


cDNA:



(SEQ ID NO: 17)




   1 ATGTCATTGA AGAACATAGT GAAGAACAAA TACAAAGCTA TTGGTAGAAG




 


  51 AGGGAGGTCA CACATTGCAC CAGAAGGATC ATCTGTGTCT TCTTCTTTAT



 


 101 CAACTAATGA AGGTTTAAAC CAGAGTATTT GGGTTGATTT GCCTCCAGAG



 


 151 TTACTTCTTG ATATAATCCA AAGGATTGAG TCTGAACAGA GTTTATGGCC



 


 201 GGGGAGGAGA GATGTTGTTG CTTGTGCTTC GGTTTGTAAG TCATGGAGGG



 


 251 AGATGACTAA AGAAGTTGTT AAAGTTCCTG AGCTCTCTGG TTTGATCACG



 


 301 TTTCCGATTT CTTTAAGACA GCCTGGACCT AGAGATGCTC CAATTCAATG



 


 351 CTTTATTAAA CGTGAAAGAG CTACGGGGAT ATACCGTCTC TATCTTGGTT



 


 401 TAAGCCCTGC TCTTTCCGGT GACAAGAGTA AGTTGTTGTT ATCTGCAAAG



 


 451 AGAGTCAGGA GAGCGACGGG TGCGGAGTTT GTTGTATCGT TATCGGGGAA



 


 501 TGACTTCTCG AGAAGTAGTA GTAATTACAT AGGAAAACTG AGATCAAATT



 


 551 TCCTGGGAAC GAAGTTCACA GTCTACGAAA ACCAACCTCC TCCGTTTAAC



 


 601 CGAAAGCTCC CACCATCGAT GCAAGTGTCT CCATGGGTAT CGTCGTCATC



 


 651 TAGTAGTTAC AACATAGCTT CAATCTTGTA TGAGCTGAAT GTTCTGAGAA



 


 701 CCAGAGGTCC AAGAAGAATG CAATGTATAA TGCACAGTAT CCCGATTTCA



 


 751 GCGATTCAAG AAGGCGGCAA AATCCAGTCG CCAACGGAGT TCACAAACCA



 


 801 AGGAAAGAAG AAGAAGAAGC CGCTGATGGA TTTCTGCTCA GGGAACCTGG



 


 851 GAGGAGAATC CGTTATAAAA GAACCATTAA TTCTGAAAAA CAAGTCGCCG



 


 901 AGATGGCACG AACAGCTTCA GTGCTGGTGT CTAAACTTCA AAGGTCGAGT



 


 951 CACAGTCGCC TCGGTGAAAA ACTTCCAGCT AGTGGCAGCT GCTGCAGAAG



 


1001 CAGGGAAGAA CATGAACATA CCAGAAGAGG AACAAGATAG AGTGATATTA



 


1051 CAGTTTGGGA AGATAGGCAA AGACATTTTC ACAATGGATT ATCGTTACCC



 


1101 GATCTCTGCA TTCCAAGCTT TTGCTATTTG TTTAAGCAGC TTCGACACGA



 


1151 AGCCAGTCTG CGAA



 


AtTLP7:



polypeptide:



(SEQ ID NO: 7)




   1 MPLSRSLLSR RISNSFRFHQ GETTTAPESE SIPPPSNMAG SSSWSAMLPE




 


  51 LLGEIIRRVE ETEDRWPQRR DVVTCACVSK KWREITHDFA RSSLNSGKIT



 


 101 FPSCLKLPGP RDFSNQCLIK RNKKTSTFYL YLALTPSFTD KGKFLLAARR



 


 151 FRTGAYTEYI ISLDADDFSQ GSNAYVGKLR SDFLGTNFTV YDSQPPHNGA



 


 201 KPSNGKASRR FASKQISPQV PAGNFEVGHV SYKFNLLKSR GPRRMVSTLR



 


 251 CPSPSPSSSS AGLSSDQKPC DVTKIMKKPN KDGSSLTILK NKAPRWHEHL



 


 301 QCWCLNFHGR VTVASVKNFQ LVATVDQSQP SGKGDEETVL LQFGKVGDDT



 


 351 FTMDYRQPLS AFQAFAICLT SFGTKLACE



 


cDNA:



(SEQ ID NO: 18)




   1 ATGCCTTTGT CACGGTCCCT CCTTTCGCGG AGGATCTCGA ACTCTTTTAG




 


  51 GTTTCATCAG GGAGAGACAA CGACGGCACC GGAATCCGAA TCGATTCCTC



 


 101 CGCCGTCGAA TATGGCCGGT TCTTCGTCAT GGTCGGCGAT GCTCCCTGAA



 


 151 TTATTAGGCG AGATCATTCG TCGCGTGGAG GAGACTGAGG ACCGTTGGCC



 


 201 TCAACGTCGT GATGTAGTTA CTTGCGCTTG CGTTTCTAAG AAATGGAGAG



 


 251 AAATCACTCA CGATTTCGCT AGATCCTCTC TTAACTCTGG CAAAATTACT



 


 301 TTCCCTTCTT GCCTCAAATT GCCAGGTCCT AGAGACTTTT CTAATCAGTG



 


 351 CTTGATAAAG AGGAACAAGA AGACATCAAC GTTTTACTTG TATCTTGCTC



 


 401 TAACACCATC ATTCACTGAT AAGGGAAAGT TTCTTCTGGC GGCGCGGAGG



 


 451 TTTAGGACCG GTGCTTACAC TGAGTACATC ATATCACTTG ATGCTGATGA



 


 501 TTTCTCTCAA GGAAGTAATG CCTACGTCGG AAAATTAAGA TCAGATTTTC



 


 551 TTGGGACCAA CTTTACAGTA TACGATAGCC AACCACCACA CAACGGAGCA



 


 601 AAACCTTCAA ATGGCAAAGC CAGTCGCAGA TTTGCATCAA AGCAGATAAG



 


 651 CCCTCAAGTT CCAGCAGGCA ACTTTGAAGT CGGTCATGTT TCTTATAAAT



 


 701 TCAACCTTTT GAAATCAAGA GGTCCAAGAA GAATGGTAAG CACACTCCGA



 


 751 TGCCCATCAC CATCACCTTC ATCATCATCC GCTGGACTCT CGTCTGACCA



 


 801 AAAGCCATGT GATGTAACCA AGATAATGAA AAAACCCAAC AAGGATGGTT



 


 851 CCAGCTTGAC AATACTAAAG AACAAAGCTC CTAGATGGCA CGAGCACTTG



 


 901 CAGTGCTGGT GTCTGAACTT CCATGGACGA GTTACTGTTG CTTCGGTCAA



 


 951 GAACTTTCAG CTGGTTGCGA CCGTTGACCA AAGTCAACCG AGCGGTAAAG



 


1001 GCGATGAAGA AACAGTTCTT CTACAGTTTG GTAAAGTGGG AGATGACACT



 


1051 TTCACTATGG ATTATAGACA GCCTCTCTCT GCATTTCAGG CTTTTGCTAT



 


1101 CTGTCTCACA AGTTTCGGCA CTAAACTTGC CTGCGAG 



 


AtTLP8:



polypeptide:



(SEQ ID NO: 8)




   1 MAGSRKVNDL LEENKGNVDT ITGSLSTQKG EDKENVSPEK VSTSVETRKL




 


  51 DRALKSQSMK GNSGFPTEVT NFKSFSTGGR TALKQSSLQA CMQKNSEVDK



 


 101 SSFGMKTWTS VDSEHSSSLK VWEFSDSEAA PASSWSTLPN RALLCKTLPL



 


 151 DVGRCTCLIV KEQSPEGLSH GSVYSLYTHE GRGRKDRKLA VAYHSRRNGK



 


 201 SIFRVAQNVK GLLCSSDESY VGSMTANLLG SKYYIWDKGV RVGSVGKMVK



 


 251 PLLSVVIFTP TITTWTGSYR RMRTLLPKQQ PMQKNNNKQV QQASKLPLDW



 


 301 LENKEKIQKL CSRIPHYNKI SKQHELDFRD RGRTGLRIQS SVKNFQLTLT



 


 351 ETPRQTILQM GRVDKARYVI DFRYPFSGYQ AFCICLASID SKLCCTV



 


cDNA:



(SEQ ID NO: 19)




   1 ATGGCTGGTT CGAGAAAAGT GAATGATTTG TTGGAGGAAA ATAAGGGAAA




 


  51 TGTGGACACA ATTACAGGGT CTTTATCCAC TCAAAAGGGA GAGGATAAGG



 


 101 AGAATGTGTC GCCGGAGAAA GTCTCTACCT CTGTGGAAAC TCGGAAACTA



 


 151 GATCGAGCTT TGAAGTCTCA ATCGATGAAG GGTAACTCTG GGTTTCCAAC



 


 201 GGAAGTTACA AATTTCAAAT CTTTCTCAAC TGGTGGTCGA ACAGCTCTGA



 


 251 AGCAGTCATC ACTGCAAGCG TGTATGCAGA AGAACAGTGA GGTTGATAAG



 


 301 AGTAGTTTCG GAATGAAAAC TTGGACTAGT GTTGATTCAG AGCATTCAAG



 


 351 TTCGTTGAAA GTGTGGGAGT TTTCGGATTC TGAAGCTGCC CCTGCTTCCT



 


 401 CTTGGTCTAC TTTGCCCAAC AGGGCTTTGT TGTGCAAGAC ACTACCTTTG



 


 451 GATGTGGGAA GATGCACTTG TCTGATTGTG AAAGAACAAT CACCTGAAGG



 


 501 CTTGAGCCAC GGATCTGTAT ATTCACTTTA TACACATGAA GGTCGGGGGC



 


 551 GTAAAGACCG GAAGTTAGCA GTTGCTTACC ATAGCCGACG TAATGGGAAA



 


 601 TCTATATTTA GGGTGGCACA GAATGTTAAG GGATTGCTGT GCAGTTCGGA



 


 651 TGAAAGTTAT GTCGGTTCCA TGACGGCTAA TCTCTTGGGT TCCAAGTACT



 


 701 ACATATGGGA CAAGGGAGTT CGAGTTGGTT CTGTAGGTAA AATGGTGAAG



 


 751 CCGCTTCTTT CGGTTGTAAT ATTCACACCC ACCATAACAA CTTGGACAGG



 


 801 GAGCTACAGA AGAATGAGAA CTTTGCTACC AAAGCAGCAG CCAATGCAGA



 


 851 AAAACAACAA TAAGCAGGTT CAACAAGCTA GTAAACTACC GCTTGATTGG



 


 901 CTTGAGAATA AGGAAAAAAT TCAGAAGCTA TGCTCAAGGA TACCACATTA



 


 951 CAACAAAATC TCCAAGCAGC ATGAGTTAGA CTTCAGAGAC AGAGGAAGAA



 


1001 CAGGACTGAG AATACAGAGC TCGGTGAAGA ACTTTCAGCT AACACTCACG



 


1051 GAGACTCCAA GGCAGACAAT TCTTCAAATG GGGAGAGTTG ACAAAGCAAG



 


1101 ATATGTAATC GACTTCAGGT ATCCATTCTC AGGCTACCAA GCATTCTGCA



 


1151 TTTGCTTGGC TTCTATTGAT TCCAAGCTTT GTTGTACTGT T



 


AtTLP9:



polypeptide:



(SEQ ID NO: 9)




   1 MTFRSLLQEM RSRPHRVVHA AASTANSSDP FSWSELPEEL LREILIRVET




 


  51 VDGGDWPSRR NVVACAGVCR SWRILTKEIV AVPEFSSKLT FPISLKQSGP



 


 101 RDSLVQCFIK RNRNTQSYHL YLGLTTSLTD NGKFLLAASK LKRATCTDYI



 


 151 ISLRSDDISK RSNAYLGRMR SNFLGTKFTV FDGSQTGAAK MQKSRSSNFI



 


 201 KVSPRVPQGS YPIAHISYEL NVLGSRGPRR MRCIMDTIPM SIVESRGVVA



 


 251 STSISSFSSR SSPVFRSHSK PLRSNSASCS DSGNNLGDPP LVLSNKAPRW



 


 301 HEQLRCWCLN FHGRVTVASV KNFQLVAVSD CEAGQTSERI ILQFGKVGKD



 


 351 MFTMDYGYPI SAFQAFAICL SSFETRIACE



 


cDNA:



(SEQ ID NO: 20)




   1 ATGACGTTCC GAAGTTTACT CCAGGAAATG CGGTCTAGGC CACACCGTGT




 


  51 AGTTCACGCC GCCGCCTCAA CCGCTAATAG TTCAGACCCT TTCAGCTGGT



 


 101 CGGAGCTCCC GGAGGAGCTG CTTAGAGAAA TCCTGATTAG GGTTGAGACT



 


 151 GTTGACGGCG GCGATTGGCC GTCGCGGCGA AACGTGGTGG CTTGTGCCGG



 


 201 CGTTTGTCGT AGCTGGAGGA TTCTCACCAA GGAGATTGTA GCTGTTCCTG



 


 251 AATTCTCCTC TAAATTGACT TTCCCTATCT CCCTCAAGCA GTCTGGTCCA



 


 301 AGAGATTCTC TAGTTCAATG CTTTATAAAA CGTAATCGAA ATACTCAATC



 


 351 GTATCATCTC TATCTCGGAT TAACTACCTC TTTGACGGAT AACGGGAAGT



 


 401 TTCTTCTTGC TGCTTCTAAG CTGAAGCGCG CAACTTGCAC TGATTACATC



 


 451 ATCTCTTTGC GTTCAGACGA TATCTCAAAG AGAAGCAACG CGTATCTTGG



 


 501 GAGAATGAGA TCGAACTTCC TTGGAACAAA ATTCACGGTC TTTGATGGTA



 


 551 GTCAGACCGG AGCAGCGAAG ATGCAGAAGA GCCGCTCTTC TAATTTCATC



 


 601 AAAGTTTCAC CTAGAGTTCC TCAGGGAAGT TACCCCATCG CTCACATTTC



 


 651 ATACGAGTTA AACGTCTTAG GCTCTCGGGG ACCGAGAAGA ATGCGTTGCA



 


 701 TCATGGATAC AATACCTATG AGCATCGTGG AGTCGCGAGG AGTAGTAGCT



 


 751 TCAACATCCA TAAGCTCTTT TTCCAGTCGG TCATCACCAG TCTTTAGGTC



 


 801 TCACTCAAAA CCATTGCGCA GTAATAGTGC ATCATGTAGC GACTCAGGCA



 


 851 ACAACCTGGG AGATCCACCA TTGGTGCTGA GCAACAAAGC TCCACGGTGG



 


 901 CATGAGCAGT TACGTTGCTG GTGCTTAAAT TTCCATGGTC GAGTCACAGT



 


 951 GGCTTCGGTT AAGAACTTTC AGCTTGTGGC AGTTAGTGAC TGTGAAGCAG



 


1001 GGCAGACATC TGAGAGGATC ATACTCCAGT TTGGGAAAGT TGGGAAGGAC



 


1051 ATGTTTACCA TGGATTATGG ATATCCGATT TCTGCGTTTC AAGCGTTTGC



 


1101 TATCTGCCTG AGCAGTTTTG AAACCAGAAT TGCCTGTGAA



 


AtTLP10:



polypeptide:



(SEQ ID NO: 10)




   1 MSFRGIVQDL RDGFGSLSRR SFDFRLSSLH KGKAQGSSFR EYSSSRDLLS




 


  51 PVIVQTSRWA NLPPELLFDV IKRLEESESN WPARKHVVAC ASVCRSWRAM



 


 101 CQEIVLGPEI CGKLTFPVSL KQPGPRDAMI QCFIKRDKSK LTFHLFLCLS



 


 151 PALLVENGKF LLSAKRTRRT TRTEYIISMD ADNISRSSNS YLGKLRSNFL



 


 201 GTKFLVYDTQ PPPNTSSSAL ITDRTSRSRF HSRRVSPKVP SGSYNIAQIT



 


 251 YELNVLGTRG PRRMHCIMNS IPISSLEPGG SVPNQPEKLV PAPYSLDDSF



 


 301 RSNISFSKSS FDHRSLDFSS SRFSEMGISC DDNEEEASFR PLILKNKQPR



 


 351 WHEQLQCWCL NFRGRVTVAS VKNFQLVAAR QPQPQGTGAA AAPTSAPAHP



 


 401 EQDKVILQFG KVGKDMFTMD YRYPLSAFQA FAICLSSFDT KLACE



 


cDNA:



(SEQ ID NO: 21)




   1 ATGTCGTTTC GAGGCATTGT TCAAGATTTG AGAGATGGGT TTGGGAGCTT




 


  51 GTCAAGGAGG AGTTTCGATT TTAGGCTCTC GAGTCTTCAT AAAGGGAAAG



 


 101 CTCAGGGTTC TTCGTTCCGT GAGTATTCGT CATCCCGTGA TCTCTTGTCG



 


 151 CCTGTGATAG TTCAGACAAG TAGATGGGCT AATCTTCCTC CAGAGTTACT



 


 201 CTTTGATGTG ATCAAAAGAT TAGAGGAAAG TGAGAGTAAT TGGCCTGCAA



 


 251 GAAAACATGT TGTGGCTTGT GCTTCGGTTT GTCGGTCTTG GAGAGCTATG



 


 301 TGCCAAGAGA TTGTTTTGGG GCCTGAAATC TGTGGGAAAC TCACTTTCCC



 


 351 TGTTTCCCTC AAACAGCCAG GGCCTCGTGA TGCAATGATT CAGTGTTTCA



 


 401 TCAAAAGGGA TAAATCAAAG CTAACATTTC ACCTTTTTCT TTGTTTAAGT



 


 451 CCCGCTCTAT TAGTGGAGAA TGGGAAATTT CTTCTTTCAG CTAAAAGAAC



 


 501 TCGTAGAACT ACTCGAACCG AGTACATTAT CTCCATGGAT GCTGATAACA



 


 551 TCTCAAGATC CAGCAACTCT TACCTCGGAA AGCTCAGATC AAACTTCCTT



 


 601 GGGACAAAGT TCTTGGTGTA CGACACGCAA CCACCACCAA ACACATCTTC



 


 651 GAGCGCACTT ATCACTGATC GAACAAGCCG AAGCAGGTTT CACTCCAGAC



 


 701 GAGTTTCTCC TAAAGTACCA TCCGGAAGCT ACAACATTGC TCAAATCACC



 


 751 TATGAGCTCA ACGTGTTGGG CACACGCGGG CCACGACGAA TGCACTGCAT



 


 801 CATGAACTCC ATCCCAATTT CATCGCTCGA ACCAGGCGGT TCAGTCCCTA



 


 851 ACCAACCCGA GAAACTCGTC CCTGCACCAT ACTCTCTCGA CGACTCATTC



 


 901 CGCAGTAACA TCTCCTTCTC CAAATCATCA TTTGACCACC GCTCCCTCGA



 


 951 TTTCAGCAGT TCTAGATTCT CCGAAATGGG AATATCCTGC GACGACAACG



 


1001 AAGAAGAAGC GAGTTTCAGA CCGTTGATTC TAAAGAACAA GCAGCCAAGG



 


1051 TGGCACGAGC AGTTGCAATG CTGGTGTTTG AATTTCCGCG GACGTGTGAC



 


1101 AGTTGCATCG GTTAAGAATT TCCAGCTTGT AGCAGCAAGA CAGCCGCAGC



 


1151 CTCAAGGGAC AGGTGCAGCA GCAGCACCAA CAAGTGCACC TGCTCACCCT



 


1201 GAGCAAGACA AGGTGATTCT CCAGTTTGGT AAAGTAGGGA AAGATATGTT



 


1251 CACAATGGAC TATAGGTATC CATTATCGGC GTTTCAGGCG TTTGCGATAT



 


1301 GCTTAAGCAG CTTTGACACC AAGCTTGCTT GTGAA



 


AtTLP11:



polypeptide:



(SEQ ID NO: 11)




   1 MRSRPHRVVH DLAAAAAADS TSVSSQDYRW SEIPEELLRE ILIRVEAADG




 


  51 GGWPSRRSVV ACAGVCRGWR LLMNETVVVP EISSKLTFPI SLKQPGPRDS



 


 101 LVQCFIKRNR ITQSYHLYLG LTNSLTDDGK FLLAACKLKH TTCTDYIISL



 


 151 RSDDMSRRSQ AYVGKVRSNF LGTKFTVFDG NLLPSTGAAK LRKSRSYNPA



 


 201 KVSAKVPLGS YPVAHITYEL NVLGSRGPRK MQCLMDTIPT STMEPQGVAS



 


 251 EPSEFPLLGT RSTLSRSQSK PLRSSSSHLK ETPLVLSNKT PRWHEQLRCW



 


 301 CLNFHGRVTV ASVKNFQLVA AGASCGSGTG MSPERQSERI ILQFGKVGKD



 


 351 MFTMDYGYPI SAFQAFAICL SSFETRIACE



 


cDNA:



(SEQ ID NO: 22)




   1 ATGCGTTCGA GACCGCATCG TGTGGTCCAC GACCTTGCCG CCGCCGCAGC




 


  51 TGCCGATTCC ACTTCTGTGT CATCGCAAGA TTATCGCTGG TCAGAGATTC



 


 101 CTGAAGAGCT TCTTAGGGAG ATTCTGATTC GTGTTGAAGC GGCGGACGGT



 


 151 GGCGGATGGC CGTCACGACG CAGCGTGGTG GCTTGTGCCG GCGTTTGTCG



 


 201 TGGCTGGCGG CTACTTATGA ACGAAACCGT CGTTGTCCCT GAGATCTCTT



 


 251 CTAAGTTGAC TTTCCCCATC TCTCTCAAGC AGCCTGGTCC AAGGGATTCA



 


 301 CTGGTTCAAT GCTTTATCAA ACGTAATCGA ATTACGCAAT CATATCATCT



 


 351 CTATCTCGGA TTAACCAACT CTTTAACGGA TGATGGGAAG TTTTTGCTTG



 


 401 CTGCGTGTAA GTTGAAGCAC ACAACTTGTA CGGATTACAT TATCTCTTTA



 


 451 CGTTCTGATG ATATGTCGAG AAGAAGCCAA GCTTATGTTG GCAAAGTGAG



 


 501 ATCGAACTTC CTAGGAACGA AATTCACTGT CTTTGATGGA AATCTGCTGC



 


 551 CTTCAACGGG AGCCGCAAAG TTGAGAAAGA GCCGATCTTA TAATCCCGCA



 


 601 AAAGTTTCAG CAAAAGTTCC TCTTGGAAGT TATCCTGTCG CTCATATCAC



 


 651 ATATGAGCTG AATGTCTTAG GATCCCGGGG ACCAAGAAAG ATGCAATGTC



 


 701 TTATGGACAC AATACCTACA AGCACAATGG AGCCTCAAGG AGTAGCTTCA



 


 751 GAACCATCAG AGTTTCCCTT ACTCGGTACT CGGTCAACCT TATCCAGGTC



 


 801 TCAGTCAAAA CCATTACGCA GTAGCTCAAG CCACCTGAAA GAAACACCAT



 


 851 TAGTGCTGAG CAACAAGACA CCACGGTGGC ACGAGCAGCT ACGCTGCTGG



 


 901 TGCTTGAATT TCCATGGCCG TGTCACAGTA GCGTCAGTGA AGAACTTTCA



 


 951 GCTCGTGGCA GCAGGAGCTA GCTGTGGCAG TGGCACGGGA ATGTCACCGG



 


1001 AGAGGCAGAG CGAGCGGATT ATATTGCAGT TTGGGAAAGT CGGGAAAGAT



 


1051 ATGTTCACGA TGGATTATGG ATACCCGATC TCAGCTTTCC AGGCTTTTGC



 


1101 CATTTGCTTG AGCAGCTTTG AGACTAGAAT CGCTTGTGAA 







Accordingly, one aspect of the invention features an isolated polypeptide containing an amino acid sequence at least 70% (i.e., any number between 70% and 100%, inclusive) identical to one of SEQ ID NOs: 1-11. When expressed in a plant cell, e.g., an Arabidopsis cell, the polypeptide regulates the transcription of genes, in response to environmental stimuli. The polypeptide of the invention can be used to identify DNA elements, such as promoters, enhances, or silencers, which it binds to. Such DNA elements mediate the response of plants to various environmental factors. The polypeptide of the invention can also be used for producing anti-AtTLP antibodies (either monoclonal or polyclonal). These antibodies in turn are useful for detecting the presence and distribution of AtTLP proteins in tissues and in cellular compartments. For example, such antibodies can be used to verify the expression of TLP proteins in a transgenic plant.
An isolated polypeptide refers to a polypeptide substantially free from naturally associated molecules, i.e., it is at least 75% (i.e., any number between 75% and 100%, inclusive) pure by dry weight. Purity can be measured by any appropriate standard method, for example, by column chromatography, polyacrylamide gel electrophoresis, or HPLC analysis.
The percent identity of two amino acid sequences is determined using the algorithm of Karlin and Altschul ((1990) Proc. Natl. Acad. Sci. USA 87, 2264-2268), modified as in Karlin and Altschul ((1993) Proc. Natl. Acad. Sci. USA 90, 5873-5877). Such an algorithm is incorporated into the XBLAST programs of Altschul, et al. ((1990) J. Mol. Biol. 215, 403-410). BLAST protein searches are performed with the XBLAST program, score=50, wordlength=3. Where gaps exist between two sequences, Gapped BLAST is utilized as described in Altschul, et al. ((1997) Nucleic Acids Res. 25, 3389-3402). When employing BLAST and Gapped BLAST programs, one can conveniently use the default parameters (e.g., XBLAST). See ncbi.nlm.nih.gov.
The invention further features (1) an isolated nucleic acid encoding a polypeptide of the invention and (2) an isolated nucleic acid that, under a high stringent condition, hybridizes to a probe containing a sequence selected from the group consisting of SEQ ID NOs: 12-22, or a complement of any selected sequence. Such a nucleic acid is at least 15 (e.g., at least 30, 50, 100, 200, 500, or 1000) nucleotides in length. By hybridization under a high stringent condition is meant hybridization at 65° C., 0.5×SSC, followed by washing at 45° C., 0.1×SSC. The nucleic acids of the invention can be used to determine whether an AtTLP mRNA is expressed in a tissue or cell. The nucleic acids can be used as primers in PCR-based detection methods, or as labeled probes in nucleic acid blots (e.g., Northern blots).
An isolated nucleic acid refers to a nucleic acid the structure of which is not identical to that of any naturally occurring nucleic acid or to that of any fragment of a naturally occurring genomic nucleic acid. The term therefore covers, for example, (a) a DNA which has the sequence of part of a naturally occurring genomic DNA molecule but is not flanked by both of the coding sequences that flank that part of the molecule in the genome of the organism in which it naturally occurs; (b) a nucleic acid incorporated into a vector or into the genomic DNA of a prokaryote or eukaryote in a manner such that the resulting molecule is not identical to any naturally occurring vector or genomic DNA; (c) a separate molecule such as a cDNA, a genomic fragment, a fragment produced by polymerase chain reaction (PCR), or a restriction fragment; and (d) a recombinant nucleotide sequence that is part of a hybrid gene, i.e., a gene encoding a fusion protein.
The invention also features a vector and a host cell containing a nucleic acid of the invention. The host cell can be an E. coli, a yeast, an insect, a plant (e.g., Arabidopsis), or a mammalian cell. The vector and host cell can be used for producing a polypeptide of the invention. For this purpose, one can culture the host cell in a medium under conditions permitting expression of the polypeptide, and isolate the polypeptide.
The just-described vector and host cell can also be used for generating a transformed plant cell or a transgenic plant containing a recombinant nucleic acid that encodes a heterologous polypeptide of SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11. One can generate such a transformed plant cell by introducing into a plant cell a recombinant nucleic acid encoding such a heterologous polypeptide and expressing the polypeptide in the cell. To generate a transgenic plant, one can (1) introduce into a plant cell a recombinant nucleic acid encoding one just-described heterologous polypeptide; (2) expressing the polypeptide in the cell, and (3) cultivating the cell to generate a plant. The transformed plant cell or transgenic plant is more sensitive to environmental factors, such as high salinity, pathogens, and chilling, and therefore can be used as a sensor to detect and monitor small changes in environment, such as soil and air.
Also within the scope of this invention is a transformed plant cell (e.g., an Arabidopsis cell, a rice cell, or a poplar cell) that expresses a low level of one or more TLP genes relative to a native plant cell of the same species. In one example, this transformed plant cell has a mutated endogenous TLP gene (e.g., an endogenous gene encoding TLP11). In another example, the transformed plant cell includes an exogenous DNA construct that expresses an interfering RNA specific to the mRNA transcribed from a TLP gene. The interfering RNA can be a double-stranded hairpin RNA including a first strand corresponding to a fragment of a TLP gene and a second strand complementary to the first strand.
As used herein, the term “interfering RNA” means an RNA molecule capable of directing the degradation of an RNA transcript having a nucleotide sequence at least a portion of which is substantially the same as that of the interfering RNA, through the mechanism of RNA interference. An interfering RNA can be a small interfering RNA (siRNA), which includes two complementary single-stranded RNAs that form an intermolecular duplex. An interfering RNA can also be a short hairpin RNA (shRNA), which includes a single-stranded RNA with two self-complementary regions that allow the RNA to fold back upon itself and form a stem-loop structure with an intramolecular duplex region and an unpaired loop region. In some circumstances, interfering RNAs can be single-stranded antisense RNAs of 19 to 29 nucleotides that are complementary to a target sequence. See Martinez et al., Cell 110:563-574 (2002). In other instances, interfering RNAs are double-stranded RNAs that, upon cleavage in cells, produce siRNAs.
Compared to its wild-type counterpart, the transformed plant cell mentioned above can have a higher (by at least 30%, e.g., 50%, 90%, 100%, 200%) tolerance to salt, chilling, pathogens, oxidative stress, or water-deficit due to absence of or lowered level of the TLP proteins. The transformed plant cell can be cultivated to regenerate a transgenic plant, which is tolerant to one or more of the environmental factors listed above. A transgenic plant (e.g., Arabidopsis, rice, and poplar) that expresses a low level of TLP11 grows faster and is larger in size compared to its wild-type counterpart.
In addition, the invention features methods of making the transformed plant cell and the transgenic plant described above. These methods include introducing into a plant cell a nucleic acid (e.g., a T-DNA or a DNA construct that expresses an anti-sense or interfering RNA) that down-regulates the expression of a TLP gene. The method for making the plant further includes cultivating the transformed plant cell to regenerate a plant. Optionally, the transformed plant cell or the transgenic plant is analyzed to confirm that it possesses one or more of the features described above.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and from the claims.


DETAILED DESCRIPTION
This invention is based on an unexpected discovery that (1) overexpression of AtTLPs in Arabidopsis increases sensitivity of the plant to various environmental factors, such as salt, chilling, oxidative stress, or water-deficit; and (2) lower-leveled expression of AtTLPs increases tolerance of the plant to several environmental factors, or accelerates the growth rate and increases the size of the plant.
Accordingly, in one aspect, the invention features a transformed plant cell containing a recombinant nucleic acid that encodes a heterologous AtTLP. The AtTLP proteins useful for this invention include, Arabidopsis AtTLPs 1-11 and TLPs of other species. The plant cell can be a dicot plant cell (e.g., a tomato cell, a brassica cell, or a potato cell) or a monocot plant cell (e.g. a rice cell, a wheat cell, or a barley cell).
A transformed plant cell of the invention can be produced by introducing into a plant cell a recombinant nucleic acid that encodes a heterologous AtTLP protein and expressing the protein in the cell. Techniques for transforming a wide variety of plant cells are well known in the art and can be found in technical and scientific literature. See, for example, Weising et al., 1988, Ann. Rev. Genet. 22:421-477. To express a heterologous AtTLP gene in a plant cell, the gene can be combined with transcriptional and translational initiation regulatory sequences that direct the transcription of the gene and translation of the encoded protein in the plant cell.
For overexpression, a constitutive plant promoter may be employed. A constitutive promoter is active under most environmental conditions and states of cell differentiation. Examples of constitutive promoters include the cauliflower mosaic virus (CaMV) 35S transcription initiation region, the 1′- or 2′-promoter derived from T-DNA of Agrobacterium tumafaciens, the ACT11 and Cat3 promoters from Arabidopsis (Huang et al., 1996, Plant Mol. Biol. 33:125-139 and Zhong et al., 1996, Mol. Gen. Genet. 251:196-203), the stearoyl-acyl carrier protein desaturase gene promoter from Brassica napus (Solocombe et al., 1994, Plant Physiol. 104:1167-1176), and the GPc1 and Gpc2 promoters from maize (Martinez et al., 1989, J. Mol. Biol. 208:551-565 and Manjunath et al., 1997, Plant Mol. Biol. 33:97-112).
Alternatively, a tissue-specific promoter or an inducible promoter may be employed to direct expression of the AtTLP gene in a specific cell type or under more precise environmental or developmental control. Examples of environmental conditions that may affect transcription by inducible promoters include anaerobicity, elevation of temperature, presence of light, spray with chemicals or hormones, or infection by a pathogen. Examples of a tissue-specific promoter or an inducible promoter include the root-specific ANR1 promoter (Zhang and Forde, 1998, Science 279:407) and the photosynthetic organ-specific RBCS promoter (Khoudi et al., 1997, Gene 197:343).
For proper polypeptide expression, a polyadenylation region at the 3′-end of the coding region should be included. The polyadenylation region can be derived from the same gene, from a variety of other genes, or from T-DNA.
A marker gene can also be included to confer a selectable phenotype on plant cells. For example, the marker gene may encode a protein that confers biocide resistance, antibiotic resistance (e.g., resistance to kanamycin, G418, bleomycin, hygromycin), or herbicide resistance (e.g., resistance to chlorosulfuron or Basta).
A recombinant nucleic acid that encodes a heterologous AtTLP protein may be introduced into the genome of a desired plant host cell by a variety of conventional techniques. For example, the recombinant nucleic acid may be introduced directly into the genomic DNA of a plant cell using techniques such as polyethylene glycol precipitation, electroporation, microinjection, or ballistic methods (e.g., DNA particle bombardment). See, e.g., Paszkowski et al., 1984, EMBO J. 3:2717-2722, Fromm et al., 1985, Proc. Natl. Acad. Sci. USA 82:5824, and Klein et al., 1987, Nature 327:70-73. Alternatively, the recombinant nucleic acid may be combined with suitable T-DNA flanking regions and introduced into a conventional Agrobacterium tumefaciens host vector. The virulence functions of the Agrobacterium tumefaciens host direct the insertion of the AtTLP gene and adjacent marker into the plant cell DNA when the cell is infected by the bacteria. Agrobacterium tumefaciens-mediated transformation techniques, including disarming and use of binary vectors, are well known in the art. See, e.g., Horsch et al., 1984, Science 233:496-498; Fraley et al., 1983, Proc. Natl. Acad. Sci. USA 80:4803; and Gene Transfer to Plants, Potrykus, ed., Springer-Verlag, Berlin, 1995.
The presence and copy number of a heterologous AtTLP gene in a transgenic plant can be determined using standard methods, e.g., Southern blotting. Expression of the heterologous AtTLP gene in a transgenic plant can be confirmed by detecting and quantifying the heterologous AtTLP mRNA or protein in the transgenic plant.
The transformed plant cells thus obtained can then be cultured to regenerate a whole plant. Regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide or herbicide marker that has been introduced together with a heat shock factor gene. Plant regeneration from cultured protoplasts is described in Evans et al., Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, 1985. Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee et al., 1987, Ann. Rev. Plant Phys. 38:467-486. Once the heterologous AtTLP gene has been confirmed to be stably incorporated in the genome of a transgenic plant, it can be introduced into other plants by sexual crossing. Depending upon the species to be crossed, one or more standard breeding techniques can be used to generate the whole plant.
In another aspect, the invention features a transformed plant cell that expresses a lower level of one or more of TLPs. TLPs are a conserved protein family and exist in various plants, including Arabidopsis, Oryza sativa (rice), Lemna Paucicostata, Cicer arietinum, and Zea mays. See Yang et al., Genomics, 92:246-253 (2008). For example, TLP11 has been found in Arabidopsis (AtTLP11), rice (OsTLP11, GenBank Accession No. Q8H485, 25 Nov. 2008 and GenBank Accession No. NM—001067107, Feb. 14, 2008), and poplar (PtTLP11, GenBank Accession No. EF146852, Dec. 1, 2007). Other TLPs can be identified by homology searches, using SEQ ID NOs 1-22 or fragments thereof as queries.
The just-mentioned transformed cell can be made by introducing a mutation(s) (e.g., site mutation, insertion, and deletion) into an endogenous TLP gene in a plant cell. Any conventional mutagenesis method is applicable to produce the transformed plant cell. For example, a plant cell can be transformed with a T-DNA and then cultured under suitable conditions to allow insertion of the T-DNA into its genome. Plant cell clones that contain the T-DNA inserted into an endogenous TLP gene can then be selected via, genotyping.
Alternatively, a transformed plant cell that expresses a lower level of a TLP is made by introducing into a plant cell a DNA construct that expresses a nucleic acid (e.g., an antisense RNA or an interfering RNA) capable of lowering the expression of a TLP gene. In one example, the DNA construct expresses a siRNA. In another example, the DNA construct expresses a double-stranded RNA that, upon cleavage in vivo, produces siRNAs. The DNA construct can be introduced into the cell using one of the standard transforming techniques described above. Stable transformants can be selected using the marker genes and the selection methods also described above. A whole plant can then be regenerated from the transformed plant cells. It can be further crossed using conventional breeding techniques to generate a homozygous stable line of a transgenic plant.
The specific example below is to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever. Without further elaboration, it is believed that one skilled in the art can, based on the description herein, utilize the present invention to its fullest extent. All publications cited herein are hereby incorporated by reference in their entirety.
Identification of the AtTLP Family
A tubby consensus sequence (Pfam PF01167, Kleyn et al., 1996, Cell 85: 281-290 and Noben-Trauth et al., 1996, Nature 380: 534-538) was used to search the Arabidopsis thaliana expressed sequence tag (EST) database and the completed Arabidopsis genome sequence (The Institute of Genome Research, TIGR) with multiple BLAST algorithms to locate all the sequences sharing significant similarities with the tubby domain (P-value<0.0085). The search results revealed eleven TUBBY-like protein genes, termed AtTLP1 to AtTLP11, in the Arabidopsis genome. For each of the 11 genes, the corresponding BAC locus (The Arabidopsis Information Resource), Tentative Consensus (TC) group, AGI gene code, cDNA GenBank accession number, and predicted protein length (No. of amino acid) are summarized in Table 1 below.







TABLE 1







AtTLP family members
















cDNA






AGI Gene
GenBank
Predicted Protein


Gene Name
BAC Locus
TC group
Code
Accession No.
Length





AtTLP1
F22K20.1
TC95487
At1g76900
AF487267
455


AtTLP2
T30D6.21
TC86308
At2g18280
AY045773
394


AtTLP3
F17A22.29
TC86633
At2g47900
AY045774
406


AtTLP4
F8K4.13
—
At1g61940
—
265


AtTLP5
T10P12.9
TC102456
At1g43640
AY046921
429


AtTLP6
F8G22.1
TC90700
At1g47270
AF487268
388


AtTLP7
F12M16.22
TC88599
At1g53320
AY092403
379


AtTLP8
T24D18.17
—
At1g16070
AF487269
397


AtTLP9
F24P17.15
TC102624
At3g06380
AF487270
380


AtTLP10
F4F7.13.
TC101291
At1g25280
AF487271
445


AtTLP11
T1A4.60
—
At5g18680
AY046922
380









Gene-specific 5′ and 3′ primers were designed based on the sequence of the predicted open reading frame (ORF) and the corresponding EST in the database. The primer pairs used are listed below:









AtTLP1-5′



(SEQ ID NO: 23)



(5′-ATGTCGTTCCGTAGCATAGTTCGT-3′)



 



AtTLP1-3′



(SEQ ID NO: 24)



(5′-TTATTCGCAAGCAAGTTTTGTGTCG-3′)



 



AtTLP2-5′



(SEQ ID NO: 25)



(5′-ATGTCTTTGAAAAGCATCCTTCGTGATC-3′)



 



AtTLP2-3′



(SEQ ID NO: 26)



(5′-TTACCCTTCACATGCCGGTTTGGTGTCA-3′)



 



AtTLP3-5′



(SEQ ID NO: 27)



(5′-ATGTCCTTCAAGAGTCTCATTCAG-3′)



 



AtTLP3-3′



(SEQ ID NO: 28)



(5′-TCATTCACATGCTATCTTGGTGTC-3′)



 



AtTLP5-5′



(SEQ ID NO: 29)



(5′-ATGTCGTTTCTGAGTATTGTTCG-3′)



 



AtTLP5-3′



(SEQ ID NO: 30)



(5′-TTATTCACATGCCAATTTAGTAT-3′)



 



AtTLP6-5′



(SEQ ID NO: 31)



(5′-ATGTCATTGAAGAACATAGTGAA-3′)



 



AtTLP6-3′



(SEQ ID NO: 32)



(5′-TCATTCGCAGACTGGCTTCGTGT-3′)



 



AtTLP7-5′



(SEQ ID NO: 33)



(5′-ATGCCTTTGTCACGGTCCCTC-3′)



 



AtTLP7-3′



(SEQ ID NO: 34)



(5′-TCACTCGCAGGCAAGTTTAGTG-3′)



 



AtTLP8-5′



(SEQ ID NO: 35)



(5′-ATGGCTGGTTCGAGAAAAGTGAA-3′)



 



AtTLP8-3′



(SEQ ID NO: 36)



(5′-TCAAACAGTACAACAAAGCTTGG-3′)



 



AtTLP9-5′



(SEQ ID NO: 37)



(5′-ATGACGTTCCGAAGTTTACTCCA-3′)



 



AtTLP9-3′



(SEQ ID NO: 38)



(5′-TTATTCACAGGCAATTCTGGTTT-3′)



 



AtTLP10-5′



(SEQ ID NO: 39)



(5′-ATGTCGTTTCGAGGCATTGTTCA-3′)



 



AtTLP10-3′



(SEQ ID NO: 40)



(5′-CTATTCACAAGCAAGCTTGGTGT-3′)



 



AtTLP11-5′



(SEQ ID NO: 41)



(5′-ATGTCGTTTCTGAGTATTGTTCG-3′)



 



AtTLP11-3′



(SEQ ID NO: 42)



(5′-TTATTCACATGCCAATTTAGTAT-3′)






RT-PCR was then performed using total RNA from-2-week-old Arabidopsis seedlings. The total RNA was isolated using the TRIZOL reagent (Invitrogen) according the manufacture's direction. PolyA+-mRNA was isolated using oligo (dT)-coated magnetic beads and the PolyATract system (Promega, Madison, Wis.). First strand cDNA was synthesized from 0.5 μg PolyA+-mRNA using SuperScript II RNase H Reverse Transcriptase (Invitrogen) according to the protocol of the supplier.
The above-described gene-specific primer pairs were used for amplifying cDNA of each AtTLP gene from first-strand cDNA. PCR conditions were as follows: 3 min at 94° C.; 25 cycles of 1 min denaturation at 94° C./1 min annealing at 55° C./1 min 30 s extension at 72° C. The PCR products were purified using the QIAquick PCR purification kit (Qiagen) and subcloned into a T-easy vector (Promega). Each of these clones was verified by sequencing. Ten AtTLP cDNAs, AtTLPs 1-3 and AtTLPs 5-11, were successfully amplified.
It was found that, except for AtTLPs 2 and 11, the amino acid sequences deduced from the cDNA sequences of AtTLPs 1, 3, and 5-10 are identical to the predicted ORFs in the database. The analysis of the AtTLP2 cDNA sequence indicated that its intron3 was located between 708-781 bp whereas the predicted splicing sites for this intron located were 663 and 766 bp. The analysis of AtTLP11 cDNA sequence showed that intron2 and intron4 were located at 669-803 bp and 1334-1575 bp, respectively, whereas the computer predicted intron2 was at 621-803 bp and there was no predicted intron4. All cDNA sequences obtained from this study were submitted to GenBank.
Sequence Analysis of AtTLP Proteins
The search for all known motifs in the deduced AtTLP amino acid sequences was conducted by MOTIF SCANNING (Pagni et al., 2001, Nucleic Acids Res 29: 148-151). Multiple sequence alignment was performed using ClustalW (Thomopson et al., 1994). This analysis reveled that each AtTLP gene, except AtTLPs 4 and 8, had a well-conserved tubby domain at its C-terminus. Unlike animal TLPs, which have highly diverse N-terminal sequences, each AtTLP, except AtTLP8, had a conserved F-box (51-57 residues) containing domain (Pfam PF00646).
Pair-wise comparisons among the AtTLP proteins revealed that their tubby domains shared 30% to 80% similarities. Further analyzing the tubby domain revealed two PROSITE signature patterns: TUB1 (Prosite Accession No. PS01200) and TUB2 motif (Prosite Accession No. PS01201). The TUB1 and TUB2 motifs were located at the C-terminal of each AtTLP protein and contain 14 and 16 amino acid residues, respectively. These two TUB motifs are highly conserved among TLPs from various organisms. Though AtTLP4 and 8 do not have obvious TUB1 and TUB2 motifs, their C-terminal tubby domains are recognizable by MOTIF SCANNING (N-score>15) (Pagni et al., 1993, Nucleic Acids Res 29: 148-151).
An obvious feature of AtTLPs is the tubby domain. In the tubby domain of a mouse TUBBY protein, three positively-charged amino acid residues, R332, R363 and K330, were thought to be crucial for PI (4,5) P2 binding (Santagata et al., 2001, Science 292: 2041-2050). A sequence alignment of AtTLP tubby domains with the mouse TUBBY domain revealed a putative PI (4,5) P2 binding domain in each AtTLP, except AtTLPs 4 and 8. This suggests that AtTLPs 1-3, 4-7, and 8-11 may bind to PI (4,5) P2. It is known that the mouse TUBBY protein is a bipartite transcription regulator. Its tubby domain possesses double-stranded DNA binding activity, and its N-terminal segment seems to modulate transcription (Boggon et al., 1999, Science 286: 2119-2125). In plants, the N-terminal region of TLPs is quite different from that in mammal TLPs as AtTLP9-GAL4 DNA binding domain fusion protein failed to activate transcription from a GAL4 promoter in a heterologous system.
Location and Gene Structure Comparison of the AtTLP Gene Family
Chromosome localizations of each AtTLP genes were determined using Map View (www.arabidopsis.org/servlets/mapper) (Huala et al., 2001, Nucleic Acids Res 29: 102-105). It was found that the genes were not evenly distributed on chromosomes I, II, III, and V. Seven genes (AtTLPs 1, 4, 5, 6, 7, 8, and 10) were located on chromosome I, and two genes (AtTLPs 2 and 3) were located on chromosomes II. The other two, AtTLPs 9 and 11, were located on chromosomes II, III respectively. Although most of the AtTLP genes were located on chromosome I, no local tandem repeats or gene clusters were identified.
By comparing the sequences of the RT-PCR products and the Arabidopsis genome, the corrected exon-intron organizations of the AtTLP genes (except for AtTLP4) were determined. It was found that exon 1 contained the sequences encoding each protein's N-terminal leading sequence, the F-box, and a nine-residue spacer between the F-box and tubby domain. This result indicated that the genes might have arisen from the same ancestral gene. The sequence encoding the C-terminal tubby domain was found to distribute in exons interrupted by 2 or 3 introns. On the basis of the exon and intron composition, the AtTLP genes were classified into three groups. Each gene of the first group (AtTLPs 1, 2, 5, 6, 7, and 10) contains three introns. Each of the second group, AtTLPs 3, 9 and 11, contains an additional intron in the region encoding the C-terminal part of the tubby domain. The third and the most distinct group (AtTLPs 4 and 8) contain 5 and 8 introns, respectively.
Expression of AtTLP Genes
A coupled RT-PCR based assay was conducted to determine the expression pattern of AtTLP genes. Total RNA was isolated from roots, main and lateral stems, rosette leaves, flower clusters, and green siliques of 42-days-old soil-grown Arabidopsis. For each gene, a pair of gene-specific primers was chosen, and PCR amplifications were carried out using 15 ng of first strand cDNA synthesized as described above. Primers of ubiquitin gene, UBQ10, (5′-ATTTCTCAAAATCTTAAAAACTT-3′ (SEQ ID NO: 43)) and 5′-TGATAGTTTTCC CAGTCAAC-3′ (SEQ ID NO: 44)) were used to amplify ubiquitin, which served as an internal loading standard (Norris et al., 1993, Plant Mol. Biol. 21: 895-906).
The results showed that AtTLPs 1, 2, 3, 6, 7, 9, 10 and 11 were expressed in all organs tested, with slight variations in mRNA accumulation. In contrast, AtTLPs 5 and 8 were primarily expressed in the root, flower, and silique. The organ-specific expressions of AtTLPs 5 and 8 indicate their specific roles in particular organs.
Although the expression of AtTLP1, 2, 3, 6, 7, 9, 10 and 11 is present in all tissues tested, the possibility that these genes are expressed with cell type specificity could not be excluded. It is possible that differential expression of these AtTLP genes could only be observed when internal developmental programming was altered or specific environmental stimuli were applied to the plants. To test this hypothesis, the public Arabidopsis Functional Genomics Consortium (AFGC) microarray expression database (the Stanford Microarray Database, genome-www5.stanford.edu/MicroArray/SMD/) (Wu et al., 2001, Plant Physiol Biochem 39: 917-926) was searched. Twofold expression was used as the difference cutoff. Based on the search, the expression profiles of DNA fragments corresponding to AtTLP2, 7, 9 and 10 were summarized in Table 2 below.







TABLE 2







Microarray analysis of AtTLP genes expression













Ch2/Ch1 Normalized



Channel 1
Channel 2
(Mean)b, c













Experiment
Description
Description
AtTLP2
AtTLP7
AtTLP9
AtTLP10
















Hormone Effect








Auxin Response
msg seedlings,
msg seedlings, 10 uM
0.32
2.21





untreated
IAA for 30 min






Auxin Induction
Mock-treated
NAA-treated

0.46

2.22



Columbia roots
Columbia roots






Cytokinin response
Control
15 min cytokinin
2.19







treatment






Abscisic acid
Wild type control
Abscisic acid
0.49
2.6
0.35



Insensitive 1

insensitive 1 mutant






edr1 Mutant
Wild type leaves
edr1 mutant leaves
2.33





Downstream genes of KN1
Control
Overexpression of
0.43
2.78

4.73




KN1-GR in Columbia-0








background






Stress








Effects of Elevated
Columbia leaves
Columbia leaves
0.33





atmospheric CO2
360 ppm CO2
1000 ppm CO2






Genes involved in chilling
Cold treated Columbia
Cold treated cls8
0.22

0.15



tolerance
wild type tissue
mutant tissue






Genes involved in potassium
[K+] = 120 uM
[K+] = 2 mM

0.34

0.2


nutrition








Cadmium
Control
10 uM cadmium treated


2.72





plant






Light Signaling








Circadian rhythm time = 12.0
Time = 0 hrs
Time = 12 hrs
0.37





Phototropic stimulation
Seedlings grown in the
nph4-2 seedlings grown
2.08






dark and exposed to
in the dark and exposed







1 hr blue light
to 1 hr blue light






Protein import into
Wild type
cia-2 (mutant)



3.46


chloroplasts: CIA-2








Identification of genes in
WT leaves after
cch1 leaves after



2.02


chlorophyll starvation
exposure to 230 uE
exposure to 230 uE







for 2 days
for 2 days






Stress








Effects of Elevated
Columbia leaves
Columbia leaves
0.33





Atmospheric CO2
360 ppm CO2
1000 ppm CO2






Genes involved
Cold treated Columbia
Cold treated cls8
0.22

0.15



In chilling tolerance
wild type tissue
mutant tissue






Genes involved in
[K+] = 120 uM
[K+] = 2 mM

0.34

0.2


potassium nutrition








Cadmium
Control
10 uM cadmium


2.72





treated plant





aThese data are obtained from afgc.stanford.edu/afgc_html/site2.htm


bAll data are corresponding with fluorescence intensities greater than 500 in both channels and ch2/ch1 normalized ratio ≧2.0 or ≦0.5


cWhen searching dbEST with blastn, we find Arabidopsis EST corresponding to fragments of four AtTLPs represented on microarray data generated by AFGC. AtTLP2 is corresponding to the EST clone 289B10T7 and 173K22T7. AtTLP7 AtTLP9 and AtTLP10 are corresponding to the EST clone 173G1T7, 201E19T7 and F3E6T7, respectively.






The resulted show that factors like hormone fluctuation and environmental stimuli modulate the expression of the four AtTLP genes. As shown in Table 2, the four AtTLP genes had different responses to treatments of various hormones. AtTLP2 gene expression instantaneously increased more than twofold with cytokinin treatment but decreased to one-third after being treated with IAA. This suggests that Cytokinin and auxin play antagonistic roles in regulating AtTLP2 gene expression.
Another cytokinin-related experiment was aimed at identifying downstream genes of KN1. KN1-like protein is a homeobox transcription factor. Its overexpression upregulates cytokinin production and leads to delayed senescence (Vollbrecht et al., 1991, Nature 350: 241-243). The expression of AtTLP7 and 10 is upregulated in KN1 overexpression transgenic plant while AtTLP2 is downregulated.
The different responses of AtTLPs 7, 2, and 10 to ABA treatment is also worth noticing. In abscisic acid insensitive 1 mutant (Pei et al., 1997, Plant Cell 9: 409-423), the expression of AtTLP2 and AtTLP10 decreases by two to threefold, but AtTLP7 expression increases over twofold. Interestingly, AtTLP2 and AtTLP7 behaved oppositely to auxin treatment and in abscisic acid insensitive 1 mutant and KN1 overexpression transgenic plant. These two AtTLPs therefore may function antagonistically in regulating phytohormone-signaling pathways.
The expression level of AtTLP2 rose in the edr1 (enhanced disease resistance I) mutant leaves. The EDR1 gene encodes a putative MAP kinase similar to CTRL, a negative regulator of ethylene response in Arabidopsis (Frye et al., 2001, Proc. Nat. Acad. Sci. 98: 373-378). The edr1 mutation of Arabidopsis also confers resistance to powdery mildew disease (Frye and Innes, 1998, Plant Cell 10: 947-956). Thus, the regulation of AtTLP2 gene expression may be associated with SA-inducible and ethylene defense mechanism.
Environmental stresses also impose influences on the expression of AtTLP genes. For example, similar to the cold treatment on cls8 mutant, elevated CO2 level inhibited the expression of AtTLP2. K+ deficiency augmented the expression of AtTLPs 7 and 10 bp threefold and fivefold, respectively. Heavy metal cadmium treatment stimulated the expression of AtTLP9.
In conclusion, the expression data of these four AtTLP genes indicate their involvement in phytohormone and environmental stress signaling.
AtTLP9 Interacts with ASK1 Protein
Homology searches in the public databases reveal that TLPs were also present in multiple plant species, including Lemna paucicostata, Oryza sativa, Cicer arietinum, maize, and Arabidopsis. Unlike animal TLPs having highly diverse N-terminal sequences, plant TLPs had conserved F-box-containing domain. Sequence alignment of the F-box cores from AtTLP, TIR, UFO, COI1 and the human F-box protein Skp2 revealed conserved islands separated by regions with weak homology. Many of the conserved residues correspond with those known to be important for Skp association (Schulman et al., 2000, Nature 408: 381-386 and Zheng et al., 2002, Nature 416: 703-709).
The F-box domain, first found in cyclin-F, interacts with the protein SKP1, which interacts with the Cdc53 (Cullin) proteins, to form a so-called SCF complex. The F-box is involved in recruiting specific proteins (e.g., transcription activators or repressors) and targeting them for ubiquitin-mediated proteolysis by 26S proteosome. Analysis of the Arabidopsis genome revealed that Arabidopsis had 21 Skp1-like, or ASK, protein, which exhibited different expression patterns. Among them, ASK1 is involved in vegetative growth and reproductive development (Zhao et al., 2003, Plant Physiology 133: 203-217).
To test whether AtTLP could interact with ASK1, AtTLP9 was examined by the yeast two-hybrid analysis. Yeast two-hybrid vectors, pAD-GAL4-2.1 and pBD-GAL4 Cam (Stratagene, La Jolla, Calif.), were used for C-terminal GAL4 AD and BD fusion constructions, respectively. A 1.1-kb SalI-PstI fragment containing the entire coding region of AtTLP9 was cloned into the SalI-PstI site of the pBD-GAL4 Cam vector. A 480-bp EcoRI-PstI fragment containing the entire coding region of ASK1 (At1g75950) was cloned into the EcoRI-PstI site of the pAD-GAL4-2.1 vector. The yeast strain YRG-2 [MATa ura3-52 his3-200 ade2-101 lys2-801 trp1-901 leu2-3,112 ga14-542 ga180-538 LYS2::GAL1UAS-GAL1TATA-HIS3 URA3::(GAL43×17mer)-CYC1TATA-lacZ] was co-transformed with the two vectors. The Y2H analysis was performed according to the manufacturer's recommendations (Stratagene). The result suggested that AtTLP9 physically interacts with ASK1 to form SCF complex and acts as a factor for substrate recognition in the ubiquitin-mediated proteolysis.
Attlp9 Null Mutants and Overexpression Lines
ATLP9 was analyzed to investigate for it in vivo functions. Both loss-of-function and overexpression approaches were taken to address its biological roles.
To identify attlp9 T-DNA insertion mutant, AtTLP9 (At3g06380) was used to search the T-DNA Express database at signal.salk.edu/cgi-bin/tdnaexpress. Two attlp9 T-DNA insertion mutants (ABRC seed stock SALK—016678 and 051138) were identified and designated as attlp9-1 and attlp9-2. T3 seeds of attlp9-1 and attlp9-2 were obtained from the Arabidopsis Biological Resource Center (Ohio State University, Columbus). The position of the T-DNA within the AtTLP9 gene was re-confirmed by sequencing a PCR-amplified fragment amplified by primer pairs corresponding to the T-DNA left borders and the AtTLP9 gene specific primer. The following primer pairs were used for attlp9-1 and attlp9-2 specific amplification,









attlp9-1: N1,



(SEQ ID NO: 45)



5′-ATGACGTTCCGAAGTTTACTC-3′;



 



LBa1,











(SEQ ID NO: 46)




5′-TGGTTCACGTAGTGGGCCATC-3′;



 









attlp9-2: C1,



(SEQ ID NO: 47)



5′-TTATTCACAGGCAATTCTGGT-3′;



and



 



LBa1,



(SEQ ID NO: 46)



5′-TGGTTCACGTAGTGGGCCATC-3′.






It was found that Attlp9-1 had a T-DNA insertion in the coding sequence at codon 705, whereas attlp9-2 had an insertion in the 5′ distal region of this gene. The T-DNA insertion site of attlp9-1 was identical to that originally described in the T-DNA Express database. However, the T-DNA insertion site of attlp9-2 was in the promoter region instead of exonl as predicted in the database (the latter is supported by a potential full length cDNA corresponding to At3g06380 generated in RIKEN, accession number BT004092).
Southern blot was conducted with the nptII marker gene to determine the T-DNA insertion number in attlp9-1 and 9-2 knockout mutants. It was found that one and three T-DNA insertion events in the T4 attlp9-1 and attlp9-2 T-DNA insertion mutants, respectively.
The T-DNAs in attlp9-1 and attlp9-2 carried a gene leading to resistance to kanamycin. Homozygous analyses of attlp9-1 and attlp9-2 plants were carried out by kanamycin selection and PCR based method. RT-PCR analyses of T4 homozygous of attlp9-1 and attlp9-2 plants indicated that attlp9-1 was a null allele, whereas attlp9-2 was somewhat leaky. For the phenotype investigation, attlp9-1 and attlp9-2 T4 homozygous lines were used for detailed analysis.
Transgenic plants with overexpressing AtTLP9 were generated. An XbaI-SmaI fragment of AtTLP9 was inserted into an XbaI-SmaI site of the pBI121 Ti-vector (Clontech) to generate a 35S:: AtTLP9 sense construct. The XbaI-SmaI fragment contained the entire AtTLP9 coding region and was under the control of the 35S promoter of cauliflower mosaic virus. The constructs were introduced into Agrobacterium strain LBA4404 bp electroporation and transformed into wild-type plants by the floral dip method (Clough et al., 1998, Plant J 16: 735-743). 38 independent transgenic lines (T0 generation) were obtained. Among them, seven independent homozygous lines from the T3 sense transgenic plants were analyzed for the AtTLP9 expression. Each of these lines contained a single copy of the transgene. Two independent transgenic lines (S13-2 and S16-1) showed dramatic increases in the AtTLP9 transcript levels and were further analyzed. A number of control transgenic lines were generated by transforming with Agrobacterium with PBI121 vector alone.
The wild type Arabidopsis thaliana ecotype Columbia-0 (Col-0) and mutant abi4-1 (obtained from Dr Wan-Hsing Cheng, Institute of Botany, Academia Sinica Taipei) were used. The phenotypes of abi4-1 were confirmed as described (Söderman et al., 2000, Plant Physiol. 124: 1752-1765) prior to use.
All seeds of the above-described lines were surface sterilized with 70% ethanol for 30 s and then with 6% household bleach for 5 min before being washed five times with sterile water. For aseptic growth, they were plated on solid medium containing Murashige and Skoog salts (Invitrogen), vitamins (Duchefa), 0.7% phytoagar (Invitrogen), and 1% sucrose and transferred to a tissue culture room. For soil growth, seedlings were transferred into individual pots 8-10 days after germination and maintained in the growth chamber. Plants were grown at 22° C. under a 16-hr-light/8-hr-dark photoperiod aseptically or on soil.
The general development and growth phenotypes of the attlp9-1 and attlp9-2 knockout plants appear to be similar to those of the wild type plants. However, when seeds were plated on nutrient agar media, the germination time of mutant attlp9-1 and attlp9-2 seeds was advanced several hours compared with that of the wild type plants, whereas the selected sense line seeds (i.e., S13-2 and S16-1) germinated later than vector control seeds. It was found that 50% of the wild type seeds geminated after about 37 hour after plating. In contrast, 50% of the attlp9-1 and attlp9-2 knockout seeds geminated at hours 26-28 after plating, and 50% of the S13-2 and S16-1 seeds geminated around hours 40-42 hours after plating.
Effect of ABA on Seed Germination of Attlp9 Mutants and Overexpression Lines
It is known that seed germination is the outcome of an integration of many signals coordinated by the interactions of stage-specific developmental regulators and the competing effects of hormonal signals (Finkelstein et al., 2002, Curr. Opin. Plant. Biol. 5: 26-32). The most critical hormone promoting embryo maturation and preventing germination is ABA.
To determine whether the transgenic plants display altered ABA responses, the above-described lines were germinated on media containing various concentrations of ABA. Seeds collected at the same or similar times were used. After surface-sterilization, sterile seeds were suspended in 0.15% agarose, and kept in the dark at 4° C. for 3 days to break residual dormancy. The seeds were then plated on agar plates in six replicates containing no ABA or 0.25, 0.5, 0.75, or 1.0 μM ABA in 12-cm plastic petri dishes. Each agar plate was divided into seven sections, and 50 seeds of WT and AtTLP9 transgenic seeds were plated on each section. A seed was regarded as germinated when the radicle protruded through the seed coat.
In the presence of 1 μM ABA, the germination of sense lines seeds was further delayed and the germination rate was reduced to less than 10%. In contrast, the germination rate of attlp9-1 and attlp9-2 mutant seeds nearly reached 50%, and about 30% of wild-type seeds were able to germinate in the presence of 1 μM ABA. These results suggest that the disruption of the AtTLP9 gene affects the sensitivity of seeds to exogenous ABA.
In addition to reducing seed germination rate, ABA also inhibited the growth and the greening process in cotyledons of the sense transgenic lines. In MS agar medium containing 1 μM ABA and 1% sucrose, 90% of the 10-d-old seedlings showed developmental arrest although the radicles of most sense lines seeds emerged. In contrast, under the same conditions, attlp9-1 and attlp9-2 plants continued to grow and about 45% of the seedlings continued to develop true leaves, although at slower rates than abi4-1 mutant does. These results indicate that the alteration of AtTLP9 modulate plant's sensitivity to ABA during seed germination and early seedling development.
AtTLP9 Expression is Transiently Up-Regulated During Imbibition of Seeds
Real-time PCR experiments were conducted to quantify AtTLP9 transcript levels at seed maturation, seed germination, and early development stage. UBQ10 was used as the endogenous control (Norris et al., 1993, Plant. Mol. Biol. 21: 895-906). Primers were designed using Primer Express 1.0 software (Applied Biosystems). The primers used were:









AtTLP9 forward primer,



(SEQ ID NO: 48)



5′-TAGGCCACACCGTGTAGTTCA-3′;



 



AtTLP9 reverse primer,



(SEQ ID NO: 49)



5′-CGTCAACAGTCTCAACCCTAATCA-3′;



 



UBQ10 forward primer,



(SEQ ID NO: 50)



5′-AGAAGTTCAATGTTTCGTTTCATGTAA-3′;



and



 



UBQ10 reverse primer,



(SEQ ID NO: 51)



5′-GAACGGAAACATAGTAGAACACTTATTCA-3′.






The real-time PCR was performed in a 50 μL reaction mixture containing 500 ng first strand cDNA, 2.5 μM each primers and 1×SYBR Green PCR Master Mix (Applied Biosystems). PCR cycling was 50° C. for 2 min, 95° C. for 10 min, followed by 40 cycles of 15 sec at 95° C./1 min at 60° C. The UBQ10 mRNA quantity was set at ‘1’ and AtTLP9 expression was determined relative to control samples. Threshold cycles were determined by Sequence Detection System V. 1.7a software (Applied Biosystems). The products were quantified by the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Scoresby, Victoria, Australia).
Seed germination is divided into three phases: imbibition, increased metabolic activity, and initiation of growth (Bewley, 1997, Plant Cell 9: 1055-1066). It was found that during seed maturation and seed imbibition at 4° C. for 72 h, AtTLP9 transcripts remained at a relatively low level. When the seeds were transferred to 22° C. for further incubation, the levels rose after 8 h, peaked at 16 h, and fell rapidly after 24 h when the radicle emerged. The AtTLP9 transcripts were barely detectable afterwards. The transient expression of AtTLP9 indicated that AtTLP9 functions at stage II of seed germination as a checkpoint before radicle protrusion.
Down-Regulation of AtTLP11 Accelerates Plant Growth Rate and Increases Plant Size
A DNA construct that expresses an interfering RNA for reducing the expression level of AtTLP11 was produced following the method described in Helliwell et al., Methods, 30:289-295 (2003). Briefly, a DNA fragment containing the 3′ terminal region of the AtTLP11 gene (i.e., 851-1140 in SEQ ID NO:22) franked by attP1 and attP2 sites was amplified by PCR. It was then incubated with BP Clonase (Invitrogen) and the pHELLSGATE2 vector, which contains two copies of the ccdB gene (see Helliwell et al.). During incubation, homologous recombination occurred between the DNA fragment and the vector so that each copy of the ccdB gene was replaced by the 3′ terminal region of the AtTLP11 gene. The resultant plasmid pHELLSGATE2-AtTLP11-RNAi, containing two copies of the AtTLP11 3′ fragment in opposite orientations, produced a hairpin interfering RNA that targets AtTLP11.
The pHELLSGATE2-AtTLP11-RNAi plasmid was introduced into Arabidopsis cells following the method described above. Positive transformants were selected by kanamycin resistance screening. The transformed Arabidopsis cells were cultivated to regenerate transgenic plants. Eleven independent transgenic Arabidopsis plant lines were selected. These plant lines, expressing lower levels of AtTLP11, grew faster and were larger in size as compared to Columbia-0 (wild-type Arabidopsis).
Other Embodiments
All of the features disclosed in this specification may be combined in any combination. Each feature disclosed in this specification may be replaced by an alternative feature serving the same, equivalent, or similar purpose. Thus, unless expressly stated otherwise, each feature disclosed is only an example of a generic series of equivalent or similar features.
From the above description, one skilled in the art can easily ascertain the essential characteristics of the present invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. Thus, other embodiments are also within the scope of the following claims.

## Claims

1. An Arabidopsis plant cell transformed with a DNA construct that expresses an interfering RNA specific to an mRNA encoding Arabidopsis tubby-like protein 11 (AtTLP11), wherein said DNA construct comprises a promoter operably linked to a first DNA strand comprising the nucleotide sequence from position 851 to position 1140 of SEQ ID NO: 22 and a second DNA strand that is fully complementary to the first DNA strand, wherein the first and second DNA strands are arranged in a 5′ to 3′ direction with respect to each other, wherein the plant cell expresses said interfering RNA which is a double-stranded hairpin RNA encoded by said DNA construct, and wherein said expression results in reduced expression of AtTLP 11 protein in said transformed plant cell as compared to an untransformed Arabidopsis plant cell lacking said DNA construct.

2. A transgenic Arabidopsis plant comprising the transformed plant cell of claim 1, wherein the transgenic Arabidopsis plant is larger in size as compared to an untransformed Arabidopsis plant lacking said DNA construct.

3. A method for producing a transgenic Arabidopsis plant with an increased size, comprising providing the transformed Arabidopsis plant cell of claim 1, and cultivating the transformed Arabidopsis plant cell to regenerate a transgenic Arabidopsis plant, wherein said transgenic Arabidopsis plant expresses said interfering RNA in said plant, and wherein expression of said interfering RNA in said plant results in increased plant size as compared to an untransformed Arabidopsis plant lacking said DNA construct.